They play a key role in delivering dietary essential neutral and basic AAs that cannot be synthesized within the brain (Stoll et al., 1993
There's no known pharmacological conflict between them, and the combination is increasingly used in clinical practice for patients who want GI support and tissue recovery alongside their weight management program

The current evidence base primarily from animal studies and limited human trials suggests the following potential applications: Improved sleep quality increased proportion of slow-wave sleep, reduced sleep latency, fewer nocturnal cortisol spikes Cortisol normalisation reduced HPA hyperactivation, particularly relevant in high-stress or metabolically burdened patients Nociceptive effects several studies indicate DSIP modulates pain processing, with implications for patients whose poor sleep is pain-driven (3) Antioxidant activity may reduce oxidative stress markers, which are elevated in both sleep-deprived and insulin-resistant individuals Neuroendocrine support preliminary evidence of effects on LH, FSH, and somatostatin hormones that regulate testosterone, oestrogen, and growth hormone release Potential stress adaptation some data suggest DSIP may reduce the physiological stress response magnitude without blunting alertness It is important to be precise here

This predictable pattern means patients can choose their injection day and meal schedule based entirely on personal convenience and side effect management rather than absorption concerns